| 1 | [SID22401288] | Active | AC50 | 0.343 | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504727, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | AC50 | 0.343 [uM] | | BioAssay | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504727 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 2 | [SID22401288] | Active | AC50 | 0.544 | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity [AID504725, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | AC50 | 0.544 [uM] | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity | | AID | 504725 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 3 | [SID22401288] | Active | Potency | 12.5893 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 4 | [SID22401288] | Active | Potency | 12.5893 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 5 | [SID22401288] | Active | Potency | 14.5659 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation [AID651600, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | Potency | 14.5659 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation | | AID | 651600 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 6 | [SID22401288] | Active | Potency | 14.5659 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation [AID651600, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | Potency | 14.5659 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation | | AID | 651600 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 7 | [SID22401288] | Active | Potency | 31.6228 | qHTS Assay for Activators of ClpP [AID651965, Type: confirmatory] | ClpP [Bacillus subtilis] [gi:2668494] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Activators of ClpP | | AID | 651965 | | BioAssay type | confirmatory | | Target | ClpP [Bacillus subtilis] [gi:2668494] | | PubMed | | | Data Table |  |
|
| 8 | [SID22401288] | Active | Potency | 79.4328 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 9 | [SID22401288] | Active | AC50 | 116.21 | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_Dose_CherryPick_Activity [AID651703, Type: confirmatory] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | AC50 | 116.21 [uM] | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_Dose_CherryPick_Activity | | AID | 651703 | | BioAssay type | confirmatory | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 10 | [SID22401288] | Active | AC50 | 116.21 | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_Dose_CherryPick_Activity [AID651703, Type: confirmatory] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | AC50 | 116.21 [uM] | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_Dose_CherryPick_Activity | | AID | 651703 | | BioAssay type | confirmatory | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 11 | [SID22401288] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 12 | [SID22401288] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 13 | [SID22401288] | Active | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 14 | [SID22401288] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID492963, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 492963 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 15 | [SID22401288] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID492963, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 492963 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 16 | [SID22401288] | Active | | | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective agonists [AID651787, Type: screening] | GNA15 gene product [Homo sapiens] [gi:156104883] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective agonists | | AID | 651787 | | BioAssay type | screening | | Target | GNA15 gene product [Homo sapiens] [gi:156104883] | | PubMed | | | Data Table |  |
|
| 17 | [SID22401288] | Active | | | Fluorescence polarization-based cell-based high throughput confirmation assay for inhibitors of insulin-degrading enzyme (IDE) [AID435028, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based high throughput confirmation assay for inhibitors of insulin-degrading enzyme (IDE) | | AID | 435028 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 18 | [SID22401288] | Active | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 19 | [SID22401288] | Active | | | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction [AID651725, Type: screening] | six1 [Homo sapiens] [gi:1246761] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction | | AID | 651725 | | BioAssay type | screening | | Target | six1 [Homo sapiens] [gi:1246761] | | PubMed | | | Data Table |  |
|
| 20 | [SID22401288] | Active | | | Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) [AID1509, Type: screening] | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) | | AID | 1509 | | BioAssay type | screening | | Target | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] | | PubMed | | | Data Table |  |
|
| 21 | [SID22401288] | Active | | | Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) [AID1509, Type: screening] | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) | | AID | 1509 | | BioAssay type | screening | | Target | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] | | PubMed | | | Data Table |  |
|
| 22 | [SID22401288] | Active | | | Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2) [AID803, Type: screening] | Galanin receptor type 2 [gi:6016094] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2) | | AID | 803 | | BioAssay type | screening | | Target | Galanin receptor type 2 [gi:6016094] | | PubMed | | | Data Table |  |
|
| 23 | [SID22401288] | Active | | | Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR) [AID434969, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR) | | AID | 434969 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 24 | [SID22401288] | Active | | | Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR) [AID434969, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR) | | AID | 434969 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 25 | [SID22401288] | Active | | | Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR) [AID434969, Type: screening] | oxytocin receptor [Homo sapiens] [gi:32307152] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR) | | AID | 434969 | | BioAssay type | screening | | Target | oxytocin receptor [Homo sapiens] [gi:32307152] | | PubMed | | | Data Table |  |
|
| 26 | [SID22401288] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype [AID1531, Type: screening] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype | | AID | 1531 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 27 | [SID22401288] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype [AID1531, Type: screening] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype | | AID | 1531 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 28 | [SID22401288] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based high throughput assay for antagonists of the parental CHO cell line, in triplicate [AID492965, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based high throughput assay for antagonists of the parental CHO cell line, in triplicate | | AID | 492965 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID22401288] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 30 | [SID22401288] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 31 | [SID22401288] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 32 | [SID22401288] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) [AID434964, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) | | AID | 434964 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 33 | [SID22401288] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) [AID434964, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) | | AID | 434964 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 34 | [SID22401288] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) [AID434964, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) | | AID | 434964 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 35 | [SID22401288] | Active | IC50 | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. [AID1434, Type: confirmatory] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1434 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 36 | [SID22401288] | Active | IC50 | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. [AID1434, Type: confirmatory] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1434 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 37 | [SID22401288] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 38 | [SID22401288] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 39 | [SID22401288] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 40 | [SID22401288] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 41 | [SID22401288] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 42 | [SID22401288] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 43 | [SID22401288] | Active | | | Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6 [AID504406, Type: screening] | glf gene product [Mycobacterium tuberculosis H37Rv] [gi:15610945] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6 | | AID | 504406 | | BioAssay type | screening | | Target | glf gene product [Mycobacterium tuberculosis H37Rv] [gi:15610945] | | PubMed | | | Data Table |  |
|
| 44 | [SID22401288] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 45 | [SID22401288] | Active | | | uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay [AID504720, Type: screening] | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | uHTS identification of MazEF TA System activators via a fluorescence-based single-stranded RNase assay | | AID | 504720 | | BioAssay type | screening | | Target | mRNA interferase toxin, antitoxin is MazE [Escherichia coli str. K-12 substr. MG1655] [gi:16130689] | | PubMed | | | Data Table |  |
|
| 46 | [SID22401288] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). [AID1962, Type: screening] | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1). | | AID | 1962 | | BioAssay type | screening | | Target | likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498] | | PubMed | | | Data Table |  |
|
| 47 | [SID22401288] | Active | | | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction [AID2629, Type: screening] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 2629 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 48 | [SID22401288] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493008, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493008 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 49 | [SID22401288] | Active | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 50 | [SID22401288] | Active | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 22401288 | | CID | 5417607 | | Outcome | Active | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|